Decoding Alzheimer's

Catherine Arnst

首页> 外文期刊>Business week >Decoding Alzheimer's

【24h】

Decoding Alzheimer's

机译：解码阿尔茨海默氏症

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Francesco Bellini Hasn't been sleeping lately. The charged-up chairman of Neurochem Inc. is just months away from finding out if a drug developed by his Quebec-based company can actually slow the course of Alzheimer's disease. A clinical trial of the drug, Alzhemed, will wrap up in January, with results expected in the spring. "The summation of all our work and research for the last 12 years will happen in the next six months," he says.

机译：Francesco Bellini最近没有睡觉。被任命为Neurochem Inc.主席的公司距离找出总部位于魁北克的公司开发的药物是否真的可以减慢阿尔茨海默氏病的进程只有几个月的时间。该药物的临床试验Alzhemed将于1月份完成，预计将于春季发布。他说：“过去12年我们所有工作和研究的总和将在接下来的6个月内进行。”

著录项

来源
《Business week》 |2007年第4016期|p.52-58|共7页
作者
Catherine Arnst;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类贸易经济;世界经济问题;
关键词

相似文献

外文文献
中文文献
专利

1. Network pharmacology used to decode potential active ingredients in Ferula assafoetida and mechanisms for the application to Alzheimer’s disease [J] . Meng Xu, Lili Zhang, Pin Li, Journal of Traditional Chinese Medical Sciences . 2020,第2期

机译：网络药理学用于解码在 Ferula Assafoetida 中的潜在活性成分及其应用于阿尔茨海默病的机制

2. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer’s disease [J] . Shaomin Li, Ming Jin, Lei Liu, Acta Neuropathologica Communications . 2018,第1期

机译：解码具有生物活性的人类AD脑可溶性Aβ的突触功能障碍，以启发阿尔茨海默氏病的新治疗途径

3. Recent Advances: Decoding Alzheimer’s Disease With Stem Cells [J] . Yi Fang, Ting Gao, Baorong Zhang, Frontiers in Aging Neuroscience . 2018,第1期

机译：最新进展：用干细胞解码阿尔茨海默氏病

4. Hybrid CNN-SVM for Alzheimer's Disease Classification from Structural MRI and the Alzheimer's Disease Neuroimaging Initiative(ADNI) [C] . Lan Lin, Baiwen Zhang, Shuicai Wu International Conference on Biomedical Engineering, Machinery and Earth Science . 2018

机译：用于阿尔茨海默病的杂交CNN-SVM从结构MRI和阿尔茨海默病神经影像倡议（ADNI）的疾病分类

5. VLSI architectures for turbo code decoders, LDPC code decoders and list sphere decoders [D] . Zhang, Yuping 2007

机译：用于Turbo代码解码器，LDPC代码解码器和列表球形解码器的VLSI架构

6. Recent Advances: Decoding Alzheimer’s Disease With Stem Cells [O] . Yi Fang, Ting Gao, Baorong Zhang, 2018

机译：最新进展：用干细胞解码阿尔茨海默氏病

7. Integrated Transcriptomic and Neuroimaging Brain Model Decodes Biological Mechanisms in Aging and Alzheimer’s Disease [O] . Quadri Adewale, Ahmed F Khan, Felix Carbonell, 2021

机译：集成的转录组和神经影像脑模型对老化和阿尔茨海默病的生物机制进行了解码

8. Recognition and Initial Assessment of Alzheimer's Disease and Related Dementias.Clinical Practice Guideline Number 19; Early Identification of Alzheimer's Disease and Related Dementias. Quick Reference Guide for Clinicians Number 19; Early Alzheimer's Dis [R] . Costa, P. T., Williams, T. F., Albert, M. S., 1996

机译：阿尔茨海默病和相关痴呆的认可和初步评估。临床实践指南第19号;阿尔茨海默病及相关痴呆的早期鉴定。临床医生快速参考指南第19号;早期阿尔茨海默氏症

1. 人工智能破解癌症和阿尔茨海默氏症语言 [J] . . 科学观察 . 2021,第002期

2. MRI技术诊断脑缺血灶及对阿尔茨海默氏症的评估效果 [J] . 霍雷鸣 . 养生保健指南 . 2021,第033期

3. 丰富环境对阿尔茨海默氏症模型小鼠行为和神经发生的影响 [J] . 何玉欣 ,张雨微 ,雷新 . 医学理论与实践 . 2020,第011期

4. 寻找阿尔茨海默氏症的血液检测方法 [J] . 凌寒 ,肖娜·威廉姆斯 . 世界科学 . 2020,第002期

5. 针灸治疗阿尔茨海默氏症的研究进展 [J] . 陈付艳 ,陈玲 . 医药前沿 . 2019,第030期

6. 阿尔茨海默氏症模型小鼠肠道菌群的改变 [C] . . 第十四届中国实验动物科学年会 . 2018

7. 新疆汉维两民族阿尔茨海默氏症患者的牙周健康状况调查 [A] . 热依拉·居热提 . 2017

1. 用于阿尔茨海默氏症和痴呆的经颅交流动态频率刺激（TACS）系统和方法 [P] . 中国专利： CN113967317A . 2022-01-25

2. 用于治疗、预防或改善阿尔茨海默氏症的组合物、用于抑制脑神经细胞死亡的组合物、用于抑制由β淀粉样蛋白诱导的小胶质细胞激活的组合物、及用于抑制由β淀粉样蛋白诱导的PGE2、TNF-α或IL-1β产生的组合物 [P] . 中国专利： CN112351790A . 2021-02-09

3. composition, use of low dose pioglitazone, method of treating alzheimer type cognitive impairment in a human individual, treating cognitive decline in a human individual, determining the increased risk of developing alzheimer cognitive impairment in a human individual human subject at a predetermined age or age range to determine whether to administer low dose pioglitazone to a human subject for the treatment of cognitive impairment of alzheimer's type, to delay the onset of alzheimer's disease in an at-risk individual. to develop alzheimer's disease, to delay the onset of mild amnesia cognitive impairment in an individual at risk of developing alzheimer's disease, to delay the onset of preclinical alzheimer's disease in an individual at risk of developing alzheimer's disease, of delaying the onset of prodrome alzheimer's disease in an individual at risk of developing alzheime disease r, low dose pioglitazone [P] . 外国专利： BR112013017446A2 . 2017-07-04

机译：组成，低剂量吡格列酮的使用，在人类个体中治疗阿尔茨海默氏型认知障碍的方法，在人类个体中治疗认知衰退，确定在预定年龄或年龄范围内在人类个体人类受试者中发生阿尔茨海默氏认知障碍的风险增加确定是否向人类受试者施用低剂量吡格列酮以治疗阿尔茨海默氏症类型的认知障碍，以延缓高危人群的阿尔茨海默氏病发作。罹患阿尔茨海默氏病，延迟有患阿尔茨海默氏病风险的个体的轻度健忘症认知障碍的发作，延迟有患阿尔茨海默氏病风险的个体的临床前阿尔茨海默氏病的发作，延迟前列腺素性阿尔茨海默氏病的发作低剂量吡格列酮对有患阿尔茨海默病风险的个体

4. methods of identifying a genetic variant that is associated with the development of a condition of interest and a patient in a clinical trial of a treatment for alzheimer's disease, of determining increasing risks of developing a condition of interest, alzheimer's disease in a patient , a prognosis, or the risk of developing alzheimer's disease in a patient, treating a patient for alzheimer's disease, a condition of interest and alzheimer's disease in a patient, stratifying a patient into a subgroup of a clinical trial of a therapy for the treatment of alzheimer's disease, use of an active anti-alzheimer's disease agent, and kits to determine if a patient is at increased risk of developing alzheimer's disease and if a patient is responsive to treatment for a condition of interest [P] . 外国专利： BRPI0917948A2 . 2017-06-20

机译：在阿尔茨海默氏病治疗的临床试验中鉴定与目标疾病和患者发展相关的遗传变异的方法，确定在患者中发展目标疾病阿尔茨海默氏病的风险，以及预后，或在患者中罹患阿尔茨海默氏病的风险，在患者中治疗阿尔茨海默氏病，所关注的疾病和阿尔茨海默氏病的风险，将患者分为治疗阿尔茨海默氏病的临床试验的亚组，活性抗阿尔茨海默氏病药物的使用和试剂盒，以确定患者是否罹患阿尔茨海默氏病的风险增加，以及患者是否对所关注疾病的治疗有反应

5. medical systems for predicting a disease pathology and for predicting clinical outcome in an individual with uncertain cognitive status, methods for predicting the pathology of a disease and for predicting clinical outcome in an individual with uncertain cognitive status, medical system for identifying individuals who are at risk of developing alzheimer's disease, methods for identifying individuals who are at risk of developing alzheimer's disease, for determining a prognosis for a patient with alzheimer's disease and for treating a patient for alzheimer's disease , use of medical data from one or more individuals with unknown evolution to Alzheimer's disease, and, medical systems for classifying individuals as having mild cognitive impairment or Alzheimer's disease, for classifying individuals as having Alzheimer's disease or some another form of dementia and to identify additional indications for a fa rmaco [P] . 外国专利： BR112020007367A2 . 2020-09-29

机译：用于在认知状态不确定的个体中预测疾病病理和预测临床结果的医疗系统，用于在认知状态不确定的个体中预测疾病病理和预测临床结果的方法，用于识别处于危险中的个体的医学系统发展中的阿尔茨海默氏病的方法，鉴定有发展为阿尔茨海默氏病风险的个体，确定患有阿尔茨海默氏病的患者的预后以及治疗患者的阿尔茨海默氏病的方法，使用来自一个或多个进展未知的个体的医学数据阿尔茨海默氏病，以及将个人分类为轻度认知障碍或阿尔茨海默氏病的医疗系统，将个人分类为患有阿尔茨海默氏病或某种其他形式的痴呆症，并识别出患有皮肤癌的其他适应症的医疗系统

相关主题

Decoding Alzheimer's

摘要

著录项

相似文献

相关主题

期刊订阅